Cardiovascular Systems expects lowered revenues due to hurricanes Harvey, Irma

Cardiovascular Systems (NSDQ:CSII)  said today that due to hurricanes Harvey and Irma it is experiencing reduced procedure volumes and, as a result, is expecting to see 2018 1st-quarter revenues.

The St. Paul, Minn.-based company said that the impact on its revenue is “magnified due to the company’s small product portfolio and location and timing of the storms,” as the Houston and Florida markets generate over 15% of its revenue.

Cardiovascular Systems said its 1st quarter revenues are “more heavily weighted in September” as it sees an uptick in procedure volume from lower summer levels. The company said it expects to see revenues in the 1st quarter of below the range of $52.6 million to $53.6 million it provided in August, with revised revenues provided when it has more information.

“Our thoughts go out to our employees in Florida and Texas and others affected by Hurricanes Harvey and Irma. As recovery progresses, we will closely monitor conditions and the anticipated impact on our business. While these historic storms are affecting our near-term performance, they are not indicative of our long-term growth opportunity and continued market leadership position,” prez & CEO Scott Ward said in a press release.

Last month, Cardiovascular Systems released both 1-year and sub-analysis results from the Liberty 360 clinical trial of peripheral interventions, including those using its DiamondBack 360 coronary orbital atherectomy system.

The post Cardiovascular Systems expects lowered revenues due to hurricanes Harvey, Irma appeared first on MassDevice.

from MassDevice http://ift.tt/2y9asdZ